Inspire Medical SystemsINSP
INSP
0
Funds holding %
of 7,398 funds
0
Analysts bullish %
of 8 analysts
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
39% more first-time investments, than exits
New positions opened: 61 | Existing positions closed: 44
33% more funds holding in top 10
Funds holding in top 10: 6 [Q3] → 8 (+2) [Q4]
4% more funds holding
Funds holding: 341 [Q3] → 353 (+12) [Q4]
7% less repeat investments, than reductions
Existing positions increased: 116 | Existing positions reduced: 125
1.87% less ownership
Funds ownership: 113.32% [Q3] → 111.46% (-1.87%) [Q4]
13% less capital invested
Capital invested by funds: $7.13B [Q3] → $6.2B (-$927M) [Q4]
26% less call options, than puts
Call options by funds: $54.8M | Put options by funds: $73.8M
Research analyst outlook
8 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$190
20%
upside
Avg. target
$227
44%
upside
High target
$260
65%
upside
8 analyst ratings
6 positive
75%
2 neutral
25%
0 negative
0%
Truist Securities Richard Newitter 51% 1-year accuracy 22 / 43 met price target | 49%upside $235 | Buy Maintained | 11 Feb 2025 |
RBC Capital Shagun Singh 55% 1-year accuracy 37 / 67 met price target | 65%upside $260 | Outperform Reiterated | 11 Feb 2025 |
Baird Mike Polark 67% 1-year accuracy 8 / 12 met price target | 57%upside $248 | Outperform Maintained | 11 Feb 2025 |
Wells Fargo Larry Biegelsen 36% 1-year accuracy 17 / 47 met price target | 24%upside $195 | Equal-Weight Maintained | 11 Feb 2025 |
Morgan Stanley Kallum Titchmarsh 50% 1-year accuracy 1 / 2 met price target | 39%upside $220 | Overweight Maintained | 11 Feb 2025 |
Financial journalist opinion
Neutral
GlobeNewsWire
7 hours ago
Inspire Medical Systems, Inc. to Report First Quarter 2025 Financial Results on May 5, 2025
MINNEAPOLIS, April 01, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the first quarter 2025 after the close of trading on Monday, May 5. Inspire's management team will host a corresponding conference call beginning at 5:00 p.m.
Neutral
GlobeNewsWire
3 weeks ago
Inspire Medical Systems, Inc. to Present at the KeyBanc Capital Markets Healthcare Forum
MINNEAPOLIS, March 06, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the KeyBanc Capital Markets Healthcare Forum on Tuesday, March 18, 2025.
Positive
Zacks Investment Research
1 month ago
Here's Why Inspire Medical Systems (INSP) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Neutral
GlobeNewsWire
1 month ago
SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Inspire Medical Systems, Inc. (NYSE: INSP) and Encourages Long-Term Inspire Investors to Contact the Firm
PHILADELPHIA, Feb. 17, 2025 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire Medical”) on behalf of the company's long-term shareholders.
Positive
Zacks Investment Research
1 month ago
How Much Upside is Left in Inspire (INSP)? Wall Street Analysts Think 25.88%
The consensus price target hints at a 25.9% upside potential for Inspire (INSP). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Positive
Zacks Investment Research
1 month ago
INSP Stock Declines Despite Q4 Earnings Beat, Gross Margin Contracts
Inspire Medical's both geographic segments witness strong revenue growth on the back of solid product demand in the fourth quarter.
Neutral
Seeking Alpha
1 month ago
Inspire Medical Systems, Inc. (INSP) Q4 2024 Earnings Call Transcript
Inspire Medical Systems, Inc. (NYSE:INSP ) Q4 2024 Earnings Conference Call February 10, 2025 5:00 PM ET Company Participants Ezgi Yagci - Vice President of Investor Relations Tim Herbert - President & Chief Executive Officer Rick Buchholz - Chief Financial Officer Conference Call Participants Travis Steed - Bank of America Securities Danielle Antalffy - UBS Robbie Marcus - JPMorgan Chris Pasquale - Nephron Research Anthony Petrone - Mizuho Financial Group Richard Newitter - Truist Securities David Rescott - Baird Adam Maeder - Piper Sandler Larry Biegelsen - Wells Fargo Shagun Singh - RBC Capital Markets Brett Fishbin - KeyBanc Capital Markets Jon Block - Stifel Michael Polark - Wolfe Research Mike Kratky - Leerink Partners Suraj Kalia - Oppenheimer & Co. Operator Good afternoon. My name is Dilem [ph] and I'll be your conference operator today.
Positive
The Motley Fool
1 month ago
Inspire Medical's Earnings Surge in Q4
Inspire Medical Systems (INSP -0.64%), known for its innovative devices that use neurostimulation to treat sleep apnea, announced impressive fourth-quarter results on Feb. 10. Earnings per share (EPS) came in at $1.15, well ahead of the $0.73 consensus estimate.
Positive
Zacks Investment Research
1 month ago
Inspire (INSP) Reports Q4 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Inspire (INSP) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Positive
Zacks Investment Research
1 month ago
Inspire Medical Systems (INSP) Q4 Earnings and Revenues Surpass Estimates
Inspire Medical Systems (INSP) came out with quarterly earnings of $1.15 per share, beating the Zacks Consensus Estimate of $0.74 per share. This compares to earnings of $0.49 per share a year ago.
Charts implemented using Lightweight Charts™